Over the 90-day window ending January 10, 2026, Aardvark Therapeutics's three dominant insider ownership positions are held by TenPercentOwner Venture Fund Vi Pte Ltd Vickers (2.05Mn shares), Chief Executive Officer Tien-Li Lee (1.55Mn shares), Other Asset Management, Lp Cormorant (987.69K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Venture Fund Vi Pte Ltd Vickers | 2,050,902 | 19 Feb, 2025 | |
| Tien-Li Lee | Chief Executive Officer | 1,551,613 | 12 Dec, 2025 |
| Asset Management, Lp Cormorant | 987,689 | 19 Feb, 2025 | |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | 958,412 | 19 Feb, 2025 | |
| Jeffrey Chi | 133,364 | 19 Feb, 2025 | |
| Nelson Sun | Chief Financial Officer | 108,484 | 12 Dec, 2025 |
| Bryan Jones | Chief Operating Officer | 1,250 | 16 Oct, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Dec, 2025 | Tien-Li Lee | Common Stock | A | 7,000 | $14.48 | 1,551,613 | D | P |
| 11 Dec, 2025 | Nelson Sun | Common Stock | A | 3,000 | $14.40 | 108,484 | D | P |
| 15 Oct, 2025 | Tien-Li Lee | Common Stock | A | 1,229 | $4.24 | 1,544,613 | D | M |
| 15 Oct, 2025 | Bryan Jones | Common Stock | A | 1,250 | $4.24 | 1,250 | D | M |
| 15 Sep, 2025 | Tien-Li Lee | Common Stock | A | 6,500 | $9.51 | 1,539,884 | D | P |
| 15 Sep, 2025 | Tien-Li Lee | Common Stock | A | 3,500 | $9.94 | 1,543,384 | D | P |
| 12 Sep, 2025 | Tien-Li Lee | Common Stock | A | 5,000 | $8.50 | 1,533,384 | D | P |
| 11 Sep, 2025 | Tien-Li Lee | Common Stock | A | 6,000 | $7.82 | 1,528,384 | D | P |
| 10 Sep, 2025 | Tien-Li Lee | Common Stock | A | 9,000 | $7.91 | 1,522,384 | D | P |
| 09 Sep, 2025 | Nelson Sun | Common Stock | A | 6,000 | $8.07 | 105,484 | D | P |
| 28 Aug, 2025 | Tien-Li Lee | Common Stock | A | 17,209 | $4.24 | 1,513,384 | D | M |
| 14 Feb, 2025 | Asset Management, Lp Cormorant | Common Stock | A | 187,500 | $16.00 | 987,689 | I | P |
| 14 Feb, 2025 | Asset Management, Lp Cormorant | Common Stock | A | 800,189 | - | 800,189 | I | C |
| 14 Feb, 2025 | Capital Global Life Sciences Fund Iv, L.P. Decheng | Common Stock | A | 2,333,887 | - | 2,333,887 | I | C |
| 14 Feb, 2025 | Capital Global Life Sciences Fund Iv, L.P. Decheng | Common Stock | A | 625,000 | $16.00 | 2,958,887 | I | P |
| 14 Feb, 2025 | Capital Global Life Sciences Fund Iv, L.P. Decheng | - | - | 958,412 | I | |||
| 14 Feb, 2025 | Capital Global Life Sciences Fund Iv, L.P. Decheng | Common Stock | A | 333,412 | - | 333,412 | I | C |
| 14 Feb, 2025 | Capital Global Life Sciences Fund Iv, L.P. Decheng | Common Stock | A | 625,000 | $16.00 | 958,412 | I | P |
| 14 Feb, 2025 | Capital Global Life Sciences Fund Iv, L.P. Decheng | - | - | 2,958,887 | I | |||
| 14 Feb, 2025 | Venture Fund Vi Pte Ltd Vickers | Common Stock | A | 413,491 | - | 2,050,902 | I | C |